Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
The purpose of this study is to assess the safety and immunogenicity of amezosvatein (CRV-101), an investigational vaccine compared to Shingrix® for the prevention of herpes zoster in adults aged 50 y...
Safety of the Herpes Zoster Subunit Vaccine in Lupus
This randomized, double-blind, placebo-controlled, non-inferiority crossover study will evaluate the Herpes Zoster Sunbit (HZ/su) vaccine in SLE patients in order to evaluate safety and immunogenicity...
Top Cities for Herpes Clinical Trials
Herpes clinical trials are recruiting across 12 cities. Here are the cities with the most active studies:
About Herpes
Herpes simplex virus (HSV) causes recurrent infections with painful blisters, most commonly oral (HSV-1) or genital (HSV-2). It is extremely common, affecting billions worldwide. Treatment includes antiviral medications to manage outbreaks and reduce transmission.
Clinical trials are advancing new treatments for herpes. Currently, 2 studies are recruiting a combined 1,740 participants across the United States. Research is being conducted by 2 organizations including Curevo Inc, NYU Langone Health.
2026 Herpes Research Landscape
As of March 2026, the herpes clinical trial landscape includes 2 actively recruiting studies across 12 cities in the United States. These studies are collectively seeking 1,740 participants, with an average enrollment target of 870 per study.
Research is being led by 2 different organizations, including Curevo Inc, NYU Langone Health.
Geographically, herpes trials are most concentrated in Tempe, Arizona (1 trial); Coral Gables, Florida (1 trial); Oak Brook, Illinois (1 trial); Lenexa, Kansas (1 trial); Newton, Kansas (1 trial) and 7 other cities.
Featured Herpes Studies
Highlighted recruiting studies for herpes, selected by enrollment size and research scope.
Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
The purpose of this study is to assess the safety and immunogenicity of amezosvatein (CRV-101), an investigational vaccine compared to Shingrix® for the prevention of herpes zoster in adults aged 50 years and older
Safety of the Herpes Zoster Subunit Vaccine in Lupus
This randomized, double-blind, placebo-controlled, non-inferiority crossover study will evaluate the Herpes Zoster Sunbit (HZ/su) vaccine in SLE patients in order to evaluate safety and immunogenicity in patients with variable baseline clinical activities, ages and immunosuppressant exposures. The investigators hypothesize that HZ/su administration will be non-inferior to placebo with respect to t...
Frequently Asked Questions About Herpes Clinical Trials
Are there herpes clinical trials near me?
Yes, there are 2 herpes clinical trials currently recruiting across 12+ cities in the United States, including Tempe, Arizona; Coral Gables, Florida; Oak Brook, Illinois. Browse the studies above to find one at a location convenient for you.
How do I join a herpes clinical trial?
To join a herpes clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are herpes clinical trials free?
Yes, participation in herpes clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of herpes treatments are being studied?
Current herpes clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in herpes clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov